Cargando…

An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.

An immunohistochemical study has been carried out on fibre optic-biopsy specimens from patients with small cell lung cancer (SCLC) who had either died within 3 months, or who had survived more than 2 years. Long term survivors (LTS) were identified from completed clinical trials at major UK centres...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobrow, L. G., Hirsch, F. R., Hay, F. G., Happerfield, L., Skov, B. G., Law, K., Leonard, R. C., Souhami, R. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977947/
https://www.ncbi.nlm.nih.gov/pubmed/1325828
_version_ 1782135371496161280
author Bobrow, L. G.
Hirsch, F. R.
Hay, F. G.
Happerfield, L.
Skov, B. G.
Law, K.
Leonard, R. C.
Souhami, R. L.
author_facet Bobrow, L. G.
Hirsch, F. R.
Hay, F. G.
Happerfield, L.
Skov, B. G.
Law, K.
Leonard, R. C.
Souhami, R. L.
author_sort Bobrow, L. G.
collection PubMed
description An immunohistochemical study has been carried out on fibre optic-biopsy specimens from patients with small cell lung cancer (SCLC) who had either died within 3 months, or who had survived more than 2 years. Long term survivors (LTS) were identified from completed clinical trials at major UK centres and were matched for age and sex within the trial with short term survivors (STS). The panel of immunohistochemical markers included those previously reported to be associated with prognosis, and reagents representative of both neuroendocrine and epithelial differentiation. A preliminary screen of 17 antibodies identified 11 as consistently reactive on paraffin-embedded material using streptavadin-biotin immunoperoxidase. Of 186 identified patients, 110 biopsy samples were retrieved. Of these, 70 gave sufficient material for analysis. All sections were scored by three observers without knowledge of the prognosis. The analysis failed to identify any antigen whose expression was correlated with prognosis. We conclude that, in fibre-optic biopsy specimens, immunohistochemical analysis does not add prognostic information in SCLC.
format Text
id pubmed-1977947
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19779472009-09-10 An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer. Bobrow, L. G. Hirsch, F. R. Hay, F. G. Happerfield, L. Skov, B. G. Law, K. Leonard, R. C. Souhami, R. L. Br J Cancer Research Article An immunohistochemical study has been carried out on fibre optic-biopsy specimens from patients with small cell lung cancer (SCLC) who had either died within 3 months, or who had survived more than 2 years. Long term survivors (LTS) were identified from completed clinical trials at major UK centres and were matched for age and sex within the trial with short term survivors (STS). The panel of immunohistochemical markers included those previously reported to be associated with prognosis, and reagents representative of both neuroendocrine and epithelial differentiation. A preliminary screen of 17 antibodies identified 11 as consistently reactive on paraffin-embedded material using streptavadin-biotin immunoperoxidase. Of 186 identified patients, 110 biopsy samples were retrieved. Of these, 70 gave sufficient material for analysis. All sections were scored by three observers without knowledge of the prognosis. The analysis failed to identify any antigen whose expression was correlated with prognosis. We conclude that, in fibre-optic biopsy specimens, immunohistochemical analysis does not add prognostic information in SCLC. Nature Publishing Group 1992-09 /pmc/articles/PMC1977947/ /pubmed/1325828 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Bobrow, L. G.
Hirsch, F. R.
Hay, F. G.
Happerfield, L.
Skov, B. G.
Law, K.
Leonard, R. C.
Souhami, R. L.
An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.
title An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.
title_full An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.
title_fullStr An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.
title_full_unstemmed An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.
title_short An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.
title_sort immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977947/
https://www.ncbi.nlm.nih.gov/pubmed/1325828
work_keys_str_mv AT bobrowlg animmunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT hirschfr animmunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT hayfg animmunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT happerfieldl animmunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT skovbg animmunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT lawk animmunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT leonardrc animmunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT souhamirl animmunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT bobrowlg immunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT hirschfr immunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT hayfg immunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT happerfieldl immunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT skovbg immunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT lawk immunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT leonardrc immunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer
AT souhamirl immunohistochemicalinvestigationofdiagnosticbiopsymaterialtakenfromshortandlongtermsurvivorswithsmallcelllungcancer